Literature DB >> 25638346

Rheumatic Heart Disease: Causes, Symptoms, and Treatments.

Min Liu1, Lei Lu1, RongRong Sun1, Yi Zheng1, Peiying Zhang2.   

Abstract

Rheumatic heart disease is a major problem in developing countries and is the cause of most of the cardiovascular mortality in young people, leading to about 250,000 deaths per year worldwide. This disease results from an abnormal autoimmune response to group A streptococci infection in a genetically susceptible host. The acute rheumatic fever, the precursor to rheumatic heart disease, can affect various organs and lead to irreversible valve damage and heart failure. The antibiotic Penicillin is generally used for the treatment and prevention of this disease. The treatment guidelines have emphasized antibiotic prophylaxis against recurrent episodes of acute rheumatic fever which is feasible and cost effective. The early diagnosis and treatment is possible if people at risk for rheumatic heart disease in endemic areas are screened. An active surveillance with echocardiography based screening may be a useful program (Marijon et al., Lancet 379(9891):953-964, 2012). The use of vitamins, C and E, and natural antioxidants protect many heart diseases.

Entities:  

Keywords:  Antibiotics; Antioxidants; Autoimmune response; Rheumatic heart disease

Mesh:

Year:  2015        PMID: 25638346     DOI: 10.1007/s12013-015-0552-5

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  8 in total

1.  Myocardial extracellular volume assessed by cardiovascular magnetic resonance may predict adverse left ventricular remodeling in rheumatic heart disease after valvular surgery.

Authors:  Shuang Li; Simeng Wang; Jianqun Yu; Jiayu Sun; Wei Cheng; Jing Liu; Huaxia Pu; Yucheng Chen; Liqing Peng
Journal:  Quant Imaging Med Surg       Date:  2022-04

2.  A Novel Rheumatic Mitral Valve Disease Model with Ex Vivo Hemodynamic and Biomechanical Validation.

Authors:  Matthew H Park; Pearly K Pandya; Yuanjia Zhu; Danielle M Mullis; Hanjay Wang; Annabel M Imbrie-Moore; Robert Wilkerson; Mateo Marin-Cuartas; Y Joseph Woo
Journal:  Cardiovasc Eng Technol       Date:  2022-08-08       Impact factor: 2.305

3.  Bioprosthetic vs. Mechanical Mitral Valve Replacement for Rheumatic Heart Disease in Patients Aged 50-70 Years.

Authors:  Jun Yu; Wei Wang
Journal:  Front Cardiovasc Med       Date:  2022-05-31

Review 4.  Current surgical strategies and techniques of aortic valve diseases in children.

Authors:  Kun Wang; Huifeng Zhang; Bing Jia
Journal:  Transl Pediatr       Date:  2018-04

5.  Associations between ambient temperature and daily hospital admissions for rheumatic heart disease in Shanghai, China.

Authors:  Yihui Ge; Cong Liu; Yue Niu; Chen Chen; Weibing Wang; Zhijing Lin; Renjie Chen; Jing Cai; Haidong Kan
Journal:  Int J Biometeorol       Date:  2018-10-27       Impact factor: 3.787

Review 6.  The Role of Exosomes and Exosomal MicroRNA in Cardiovascular Disease.

Authors:  Dongdong Zheng; Ming Huo; Bo Li; Weitie Wang; Hulin Piao; Yong Wang; Zhicheng Zhu; Dan Li; Tiance Wang; Kexiang Liu
Journal:  Front Cell Dev Biol       Date:  2021-01-12

Review 7.  Insights Into the Involvement of Circular RNAs in Autoimmune Diseases.

Authors:  Xingyu Zhai; Yunfei Zhang; Shuyu Xin; Pengfei Cao; Jianhong Lu
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

8.  Analysis of Rheumatic Heart Disease Mortality in the Chinese Population: A JoinPoint and Age-Period-Cohort Study.

Authors:  Jiameng Cui; Xinru Guo; Xin Yuan; Hao Wu; Ge Yu; Biao Li; Changgui Kou
Journal:  Int J Environ Res Public Health       Date:  2022-08-10       Impact factor: 4.614

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.